Companies → Amedisys, Inc.
Save to list
Remove

Amedisys, Inc.

United States, Louisiana, Baton Rouge
Description
Through over 530 home health care agencies located throughout the US, Amedisys is a leading healthcare services company committed to helping its patients age in place by providing clinically excellent care and support in the home. It provides skilled nursing and home health services, primarily to geriatric patients covered by Medicare. It is also a post-acute care partner to over 3,000 hospitals and some 102,000 physicians across the country. In addition to home health services, Amedisys owns or manages about 165 hospice centers that offer palliative care to terminally ill patients. Amedisys provides home health, hospice care, personal care, and high acuity care services to more than 465,000 patients annually.
Address:

3854 American Way Ste A Baton Rouge

LA

70816-4897 United States

Website:
Revenue
Recent news:

The Pennant Group, Inc. Q4 2025 Earnings Call Summary

Moby summary of The Pennant Group, Inc.'s Q4 2025 earnings call

Source: Moby Feb 27, 2026

Pennant Group (PNTG): Assessing Valuation After Truist Upgrade and Easing 2026 Medicare Concerns

Pennant Group (PNTG) just got a confidence boost, with Truist Securities upgrading the stock after regulators outlined more forgiving 2026 Medicare home health rules and the market digested its large Amedisys acquisition integration. See our latest analysis for Pennant Group. Zooming out, Pennant’s momentum has picked up meaningfully, with a 30 day share price return of about 15 percent and a 90 day gain near 19 percent, even though the 12 month total shareholder return still sits slightly...

Source: Simply Wall St. Dec 5, 2025

The Bull Case For Pennant Group (PNTG) Could Change Following Truist Upgrade And Medicare Rule Shift

Recently, Truist Securities upgraded The Pennant Group to a “buy” rating, highlighting improving operating trends, strong demand for senior care, and reduced reimbursement risk following a more favorable 2026 Medicare home health rule. This shift in analyst sentiment, combined with smoother-than-expected integration of newly acquired Amedisys locations, points to potentially stronger operational resilience for Pennant’s home health and senior living platform. With Truist highlighting...

Source: Simply Wall St. Dec 4, 2025

BrightSpring Health Services Reports Strong Q3 2025 Results, Beats Estimates

BrightSpring Health's Q3 2025 results exceeded analyst expectations with $3.33B revenue and specialty pharmacy scripts growing over 40%, leading to raised full-year guidance despite market concerns.

Source: IndexBox Nov 4, 2025

The Pennant Group (PNTG) Stock Trades Up, Here Is Why

Shares of senior living provider The Pennant Group (NASDAQ:PNTG) jumped 2.1% in the afternoon session after the company announced it acquired certain home health, hospice, and personal care operations from UnitedHealth Group for $146.5 million.

Source: StockStory Oct 3, 2025

UnitedHealth Group Incorporated (UNH) Launches New Digital Platform to Simplify Healthcare Plans

We recently compiled a list of the 12 Most Undervalued Dow Stocks to Buy According to Analysts. UnitedHealth Group Incorporated is one of them. UnitedHealth Group Incorporated (NYSE:UNH), a leading U.S. healthcare and insurance provider, serves over 51 million members through its UnitedHealthcare and Optum divisions, offering insurance, pharmacy, and data-driven health services. In September

Source: Insider Monkey Sep 28, 2025

NASDAQ - Delayed Quote - USD
AMED
100.99 +0.01 (+0.01%)
At close March 20 20:00 UTC
Candle
Line
1D
5D
1M
6M
1Y
5Y
Financial Statistics
Valuation Measures
Current
Quarterly
As of 10/16/2025
Market Cap: 3.32 B
Enterprise Value: 3.43 B
Trailing P/E: 39.30
Forward P/E: 22.03
PEG Ratio (5yr expected): 1.47
Price/Sales (ttm): 1.39
Price/Book (mrq): 2.69
Enterprise Value/Revenue: 1.43
Enterprise Value/EBITDA: 14.39
Financial Highlights
Profitability and Income Statement
Profit Margin: 3.56%
Return on Assets (ttm): 6.52%
Return on Equity (ttm): 6.67%
Revenue (ttm): 2.40 B
Net Income Avi to Common (ttm): 85.63 M
Diluted EPS (ttm): 2.57
Balance Sheet and Cash Flow
Total Cash (mrq): 337.30 M
Total Debt/Equity (mrq): 35.34%
Levered Free Cash Flow (ttm): 300.69 M
Company is likely to buy
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.